The website and its content are not intended to be viewed and used by French & UK healthcare professionals

Symposia & Webinars

Moving from blood pressure reduction to patient protection

 

This presentation by Professor Krzysztof Narkiewicz focuses on “moving” management of arterial hypertension, analysing 2018 ESC guidelines. The word “move” refers on how a faster blood pression (BP) control can be obtained through triple combination therapy that, according to clinical data, is considered more effective.

Another important topic is perindopril/amlodipine/indapamide single pill combination (SPC) use in hypertension management and cardiovascular events prevention.

An ideal SPC treatment should be:

  • Useful in various clinical conditions and different age groups.
  • Available in double and triple combinations with several drugs.
  • Supported by EBM and suitable in providing protection.

In this context, perindopril/amlodipine/indapamide use is supported by the recent international guidelines and clinical trials because:

  • Suitable second step in hypertension management.
  • Facilitates BP control in difficult to manage hypertension.
  • Consistent with patient’s expectation.
  • Provides optimal CV protection.

This video is part of the session “Triple single-pill combination in the management of hypertension: earlier and broader use?” held virtually at ESC Congress 2020 on Sunday August 30th, 2020, with chairperson Costas Tsioufis (Greece).

View also the other parts of the congress session: